Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genomic Health Inc (GHDX)

Genomic Health Inc (GHDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,384,583
  • Shares Outstanding, K 37,588
  • Annual Sales, $ 394,110 K
  • Annual Income, $ 25,680 K
  • 60-Month Beta 0.90
  • Price/Sales 6.09
  • Price/Cash Flow 44.07
  • Price/Book 6.83
  • Price/Earnings ttm 44.67
  • Earnings Per Share ttm 1.08
  • Most Recent Earnings 0.42 on 07/29/19
  • Next Earnings Date 11/12/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.40
  • Number of Estimates 5
  • High Estimate 0.48
  • Low Estimate 0.34
  • Prior Year 0.35
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.74 +1.12%
on 11/07/19
71.50 -11.27%
on 10/15/19
-5.37 (-7.80%)
since 10/07/19
3-Month
62.74 +1.12%
on 11/07/19
77.00 -17.61%
on 08/30/19
-9.73 (-13.30%)
since 08/07/19
52-Week
50.77 +24.96%
on 06/12/19
90.18 -29.65%
on 11/08/18
-26.74 (-29.65%)
since 11/07/18

Most Recent Stories

More News
Liquid Biopsy Market Research, Developments and Precise Outlook 2019 to 2025

GHDX : 63.44 (-0.69%)
MYGN : 25.58 (+2.32%)
8.9% Return Seen to Date on SmarTrend Genomic Health I Call (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on September 27th, 2019 at $69.60. In approximately 2 months, Genomic Health I has returned 8.85% as of today's recent price of $63.44....

GHDX : 63.44 (-0.69%)
Genomic Health I Has Returned 8.9% Since SmarTrend Recommendation (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on September 27th, 2019 at $69.60. In approximately 2 months, Genomic Health I has returned 8.85% as of today's recent price of $63.44....

GHDX : 63.44 (-0.69%)
8.9% Return Seen to Date on SmarTrend Genomic Health I Call (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on September 27th, 2019 at $69.60. In approximately 2 months, Genomic Health I has returned 8.85% as of today's recent price of $63.44....

GHDX : 63.44 (-0.69%)
Downtrend Call Working As Genomic Health I Stock Falls 8.9% (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on September 27th, 2019 at $69.60. In approximately 2 months, Genomic Health I has returned 8.85% as of today's recent price of $63.44....

GHDX : 63.44 (-0.69%)
Celgene (CELG) Hits 52-Week High, Can the Run Continue?

Celgene (CELG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CELG : 108.24 (+0.10%)
REGN : 376.42 (+1.14%)
ALXN : 110.42 (-1.82%)
GHDX : 63.44 (-0.69%)
Why the Earnings Surprise Streak Could Continue for Genomic Health (GHDX)

Genomic Health (GHDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

GHDX : 63.44 (-0.69%)
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth

EXAS : 87.20 (+2.08%)
GHDX : 63.44 (-0.69%)
Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences

Genomic Health, Inc. (NASDAQ: GHDX) announced that its stockholders voted to approve the company's proposed combination with Exact Sciences Corp (NASDAQ: EXAS) at a special meeting held earlier today.

EXAS : 87.20 (+2.08%)
GHDX : 63.44 (-0.69%)
Genomic Health I Set to Possibly Rebound After Yesterday's Selloff of 7.34%

Genomic Health I (NASDAQ:GHDX) traded in a range yesterday that spanned from a low of $64.39 to a high of $65.50. Yesterday, the shares fell 7.3%, which took the trading range below the 3-day low of...

GHDX : 63.44 (-0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade GHDX with:

Business Summary

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict...

See More

Key Turning Points

2nd Resistance Point 65.41
1st Resistance Point 64.43
Last Price 63.44
1st Support Level 62.60
2nd Support Level 61.75

See More

52-Week High 90.18
Fibonacci 61.8% 75.13
Fibonacci 50% 70.47
Fibonacci 38.2% 65.82
Last Price 63.44
52-Week Low 50.77

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar